Valuation: Orthofix International NV

Market Cap 419M 362M 338M 310M 584M 39.85B 593M 3.97B 1.56B 19.97B 1.57B 1.54B 66.03B P/E 2026 *
-10.8x
P/E 2027 * -12.1x
Enterprise Value 419M 362M 338M 310M 584M 39.85B 593M 3.97B 1.56B 19.97B 1.57B 1.54B 66.03B EV / Sales 2026 *
0.49x
EV / Sales 2027 * 0.48x
Free-Float
97.82%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-07
Director of Finance/CFO 55 2024-01-14
Compliance Officer - 2015-01-31
Director TitleAgeSince
Director/Board Member 66 2016-03-15
Director/Board Member 54 2020-06-07
Director/Board Member 64 2023-01-04
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+0.91% - - 419M
-0.14%+2.00%-19.71%+2.11% 187B
+1.44%+2.07%-6.16%+5.98% 112B
-1.40%+2.93%+12.39%+72.88% 61.15B
+0.65%+3.91%+32.37%+55.21% 54.39B
-0.12%+6.79%-8.60%-37.08% 48.17B
+2.08%+1.56%+7.47%-23.09% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+46.93%-11.45% 24.92B
+2.45%+3.97%-2.22%+5.43% 23.15B
Average +0.99%+1.45%+7.81%+8.75% 63.64B
Weighted average by Cap. +0.53%+2.02%-1.67%+10.77%

Financials

2026 *2027 *
Net sales 850M 735M 686M 630M 1.18B 80.85B 1.2B 8.05B 3.16B 40.53B 3.19B 3.12B 134B 875M 757M 707M 648M 1.22B 83.27B 1.24B 8.29B 3.25B 41.74B 3.29B 3.21B 138B
Net income -36.35M -31.44M -29.36M -26.94M -50.67M -3.46B -51.47M -345M -135M -1.73B -137M -134M -5.73B -40.48M -35.01M -32.7M -29.99M -56.42M -3.85B -57.31M -384M -151M -1.93B -152M -149M -6.38B
Net Debt - -
Logo Orthofix International NV
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-